Skip to main content
Premium Trial:

Request an Annual Quote

Quintiles, Population Genetics Partner on Genomics

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Quintiles and Population Genetics Technologies today announced a partnership aimed at incorporating genomic testing into mainstream drug development.

The firms will jointly identify opportunities to apply large-scale genomic analyses to test clinical hypotheses and correlate biomarkers of disease prognosis and drug responsiveness. The non-exclusive collaboration will utilize PGT's technology for processing hundreds of genomes simultaneously in a single assay, while retaining the ability to identify each individual genome during post-sequencing data analysis, they said.

"The combination of Quintiles and PGT's capabilities can, we believe, increase the probability of success in clinical trials, reduce trial enrollment required to achieve statistical significance, and diminish the costs and/or time required to bring a product to market – all while improving product differentiation," M. King Jolly, SVP of Quintiles Innovation, said in a statement.

The first project the partners are working on is a renal cancer clinical trial to identify genetic markers of adverse events and efficacy.

PGT is based in Cambridge, UK, and was co-founded Nobel Laureate Sydney Brenner.

Research Triangle Park, NC-based Quintiles is a biopharmaceutical services company known for its efforts as a clinical research organization. It noted that its Translational R&D Oncology group offers genomic technologies for biomarker discovery.

Financial and further terms of the alliance were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.